Home/Filings/4/0001181431-07-008130
4//SEC Filing

Parhizgar Azin 4

Accession 0001181431-07-008130

CIK 0001108271other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 5:07 PM ET

Size

14.2 KB

Accession

0001181431-07-008130

Insider Transaction Report

Form 4
Period: 2007-02-01
Parhizgar Azin
VP, Chief Operating Officer
Transactions
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2007-02-01$32.31/sh372,960$12,050,3380 total
    Exercise: $1.19Exp: 2014-09-09Common Stock (372,960 underlying)
  • Disposition to Issuer

    Common Stock

    2007-02-01$33.50/sh4,869$163,1120 total
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2007-02-01$11.46/sh80,000$916,8000 total
    Exercise: $22.04Exp: 2016-01-20Common Stock (80,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2007-02-01$17.62/sh60,000$1,057,2000 total
    Exercise: $15.88Exp: 2015-05-09Common Stock (60,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to buy)

    2007-02-01$32.31/sh34,660$1,119,8650 total
    Exercise: $1.19Exp: 2014-09-09Common Stock (34,660 underlying)
Footnotes (3)
  • [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated November 16, 2006, among Conor Medsystems, Inc., Johnson & Johnson and Cypress Acquisition Sub, Inc., a wholly owned subsidiary of Johnson & Johnson (the "Merger Agreement"), each issued and outstanding share of common stock was automatically canceled and converted into the right to receive a per share amount equal to $33.50 in cash, without interest.
  • [F2]This option, which was fully vested, was canceled pursuant to the terms of the Merger Agreement, in exchange for a cash payment equal to the excess of the $33.50 per share merger consideration over the per share exercise price of the option, multiplied by the number of shares of common stock subject to the option.
  • [F3]This option, which vested in increments of one forty-eighth of the total shares subject to the option each month, was canceled pursuant to the terms of the Merger Agreement, in exchange for a cash payment equal to the excess of the $33.50 per share merger consideration over the per share exercise price of the option, multiplied by the number of shares of common stock subject to the option.

Issuer

CONOR MEDSYSTEMS INC

CIK 0001108271

Entity typeother

Related Parties

1
  • filerCIK 0001310631

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:07 PM ET
Size
14.2 KB